{ "ticker": "MO", "cik": "0000764180", "company": "Altria Group, Inc.", "business_type": "consumer staples (tobacco and nicotine products)", "schema_template": "standard consumer-products: revenue, cost of sales, gross profit, operating income, net earnings, EPS; cash, debt, assets, equity; operating cash flow, capital expenditures, free cash flow, dividends \u2014 extended with the excise-tax line and the segment operating companies income measure Altria manages the business on", "reporting_currency": "USD", "converted_to_usd": false, "units": "actual dollars (not millions); share counts in actual shares; per-share amounts in dollars per share", "units_notes_seen": { "FY2025 10-K consolidated balance sheets": "(in millions of dollars) \u2014 the continued page adds \"except share and per share data\"", "FY2025 10-K consolidated statements of earnings": "(in millions of dollars, except per share data)", "FY2025 10-K consolidated statements of cash flows": "(in millions of dollars)", "FY2025 10-K consolidated statements of stockholders' equity (deficit)": "(in millions of dollars, except per share data)", "FY2025 10-K earnings per share note (Note 12)": "(in millions)", "FY2025 10-K segment reporting note (Note 15)": "(in millions)", "Q2 2026 10-Q condensed consolidated balance sheets": "(in millions of dollars) \u2014 the continued page adds \"except share and per share data\"", "Q2 2026 10-Q condensed consolidated statements of earnings": "(in millions of dollars, except per share data)", "Q2 2026 10-Q condensed consolidated statements of cash flows": "(in millions of dollars)", "Q2 2026 10-Q condensed consolidated statements of stockholders' equity (deficit)": "(in millions of dollars, except per share data)", "Q2 2026 10-Q earnings per share note (Note 7)": "(in millions, except per share data)", "Q2 2026 10-Q segment reporting note (Note 9)": "(in millions)" }, "adjustments": { "splits_applied": [], "adr_ratio": null, "fx": "None. Altria reports in U.S. dollars and no translation was required." }, "annual": [ { "fiscal_year": 2025, "label": "FY2025", "period_start": "2025-01-01", "period_end": "2025-12-31", "period_type": "fiscal year", "source_accession": "0000764180-26-000017", "income_statement": { "net_revenues": 23279000000, "cost_of_sales": 5597000000, "excise_taxes_on_products": 3140000000, "gross_profit": 14542000000, "marketing_administration_and_research_costs": 2507000000, "asset_impairment_and_exit_costs": 978000000, "impairment_of_goodwill": 1158000000, "operating_income": 9899000000, "interest_and_other_debt_expense_net": 1079000000, "net_periodic_benefit_income_excluding_service_cost": -59000000, "income_losses_from_investments_in_equity_securities": -510000000, "gain_on_sale_of_iqos_system_commercialization_rights": 0, "earnings_before_income_taxes": 9389000000, "provision_for_income_taxes": 2442000000, "net_earnings": 6947000000, "diluted_eps": 4.12, "earnings_for_basic_and_diluted_eps": 6927000000, "diluted_shares": 1683000000, "revenues_net_of_excise_taxes": 20139000000, "dividends_declared_per_share": 4.16 }, "cash_flow": { "depreciation_and_amortization": 266000000, "net_cash_provided_by_used_in_operating_activities": 9290000000, "capital_expenditures": -216000000, "net_cash_provided_by_used_in_investing_activities": -341000000, "long_term_debt_issued": 1992000000, "long_term_debt_repaid": -1607000000, "repurchases_of_common_stock": -1000000000, "dividends_paid_on_common_stock": -6960000000, "net_cash_provided_by_used_in_financing_activities": -7615000000, "free_cash_flow": 9074000000 }, "balance_sheet": { "cash_and_cash_equivalents": 4474000000, "total_current_assets": 5932000000, "goodwill": 5787000000, "other_intangible_assets_net": 11876000000, "investments_in_equity_securities": 8617000000, "total_assets": 35017000000, "current_portion_of_long_term_debt": 1569000000, "total_current_liabilities": 9154000000, "long_term_debt": 24140000000, "total_liabilities": 38469000000, "total_stockholders_equity_attributable_to_altria": -3502000000, "noncontrolling_interest": 50000000, "total_stockholders_equity": -3452000000, "total_debt": 25709000000, "shares_outstanding_at_period_end": 1674318297 }, "segment_results": { "net_revenues": { "smokeable_products": 20485000000, "oral_tobacco_products": 2802000000, "e_vapor_products": -13000000, "all_other": 5000000 }, "operating_companies_income": { "smokeable_products": 10984000000, "oral_tobacco_products": 1828000000, "e_vapor_products": -2297000000, "all_other": -229000000 }, "amortization_of_intangibles": -132000000, "general_corporate_expenses": -255000000 } }, { "fiscal_year": 2024, "label": "FY2024", "period_start": "2024-01-01", "period_end": "2024-12-31", "period_type": "fiscal year", "source_accession": "0000764180-26-000017", "income_statement": { "net_revenues": 24018000000, "cost_of_sales": 6077000000, "excise_taxes_on_products": 3574000000, "gross_profit": 14367000000, "marketing_administration_and_research_costs": 2737000000, "asset_impairment_and_exit_costs": 389000000, "impairment_of_goodwill": 0, "operating_income": 11241000000, "interest_and_other_debt_expense_net": 1037000000, "net_periodic_benefit_income_excluding_service_cost": -102000000, "income_losses_from_investments_in_equity_securities": -652000000, "gain_on_sale_of_iqos_system_commercialization_rights": -2700000000, "earnings_before_income_taxes": 13658000000, "provision_for_income_taxes": 2394000000, "net_earnings": 11264000000, "diluted_eps": 6.54, "earnings_for_basic_and_diluted_eps": 11236000000, "diluted_shares": 1718000000, "revenues_net_of_excise_taxes": 20444000000, "dividends_declared_per_share": 4 }, "cash_flow": { "depreciation_and_amortization": 286000000, "net_cash_provided_by_used_in_operating_activities": 8753000000, "capital_expenditures": -142000000, "net_cash_provided_by_used_in_investing_activities": 2175000000, "long_term_debt_issued": 0, "long_term_debt_repaid": -1121000000, "repurchases_of_common_stock": -3400000000, "dividends_paid_on_common_stock": -6845000000, "net_cash_provided_by_used_in_financing_activities": -11491000000, "free_cash_flow": 8611000000 }, "balance_sheet": { "cash_and_cash_equivalents": 3127000000, "total_current_assets": 4513000000, "goodwill": 6945000000, "other_intangible_assets_net": 12973000000, "investments_in_equity_securities": 8195000000, "total_assets": 35177000000, "current_portion_of_long_term_debt": 1527000000, "total_current_liabilities": 8781000000, "long_term_debt": 23399000000, "total_liabilities": 37365000000, "total_stockholders_equity_attributable_to_altria": -2238000000, "noncontrolling_interest": 50000000, "total_stockholders_equity": -2188000000, "total_debt": 24926000000, "shares_outstanding_at_period_end": 1690651867 }, "segment_results": { "net_revenues": { "smokeable_products": 21204000000, "oral_tobacco_products": 2776000000, "e_vapor_products": 40000000, "all_other": -2000000 }, "operating_companies_income": { "smokeable_products": 10821000000, "oral_tobacco_products": 1449000000, "e_vapor_products": -171000000, "all_other": -243000000 }, "amortization_of_intangibles": -139000000, "general_corporate_expenses": -476000000 } }, { "fiscal_year": 2023, "label": "FY2023", "period_start": "2023-01-01", "period_end": "2023-12-31", "period_type": "fiscal year", "source_accession": "0000764180-26-000017", "income_statement": { "net_revenues": 24483000000, "cost_of_sales": 6218000000, "excise_taxes_on_products": 3981000000, "gross_profit": 14284000000, "marketing_administration_and_research_costs": 2737000000, "asset_impairment_and_exit_costs": 0, "impairment_of_goodwill": 0, "operating_income": 11547000000, "interest_and_other_debt_expense_net": 989000000, "net_periodic_benefit_income_excluding_service_cost": -127000000, "income_losses_from_investments_in_equity_securities": -243000000, "gain_on_sale_of_iqos_system_commercialization_rights": 0, "earnings_before_income_taxes": 10928000000, "provision_for_income_taxes": 2798000000, "net_earnings": 8130000000, "diluted_eps": 4.57, "earnings_for_basic_and_diluted_eps": 8113000000, "diluted_shares": 1777000000, "revenues_net_of_excise_taxes": 20502000000, "dividends_declared_per_share": 3.84 }, "cash_flow": { "depreciation_and_amortization": 272000000, "net_cash_provided_by_used_in_operating_activities": 9287000000, "capital_expenditures": -196000000, "net_cash_provided_by_used_in_investing_activities": -1283000000, "long_term_debt_issued": 998000000, "long_term_debt_repaid": -1566000000, "repurchases_of_common_stock": -1000000000, "dividends_paid_on_common_stock": -6779000000, "net_cash_provided_by_used_in_financing_activities": -8374000000, "free_cash_flow": 9091000000 }, "segment_results": { "net_revenues": { "smokeable_products": 21756000000, "oral_tobacco_products": 2667000000, "e_vapor_products": 62000000, "all_other": -2000000 }, "operating_companies_income": { "smokeable_products": 10670000000, "oral_tobacco_products": 1722000000, "e_vapor_products": -16000000, "all_other": -58000000 }, "amortization_of_intangibles": -128000000, "general_corporate_expenses": -643000000 } } ], "quarterly": [ { "label": "Q2 2026", "period_start": "2026-04-01", "period_end": "2026-06-30", "period_type": "three months", "source_accession": "0000764180-26-000094", "income_statement": { "net_revenues": 6111000000, "cost_of_sales": 1536000000, "excise_taxes_on_products": 755000000, "gross_profit": 3820000000, "marketing_administration_and_research_costs": 663000000, "asset_impairment_and_exit_costs": 21000000, "impairment_of_goodwill": 0, "operating_income": 3136000000, "interest_and_other_debt_expense_net": 295000000, "net_periodic_benefit_income_excluding_service_cost": -1000000, "income_losses_from_investments_in_equity_securities": -87000000, "earnings_before_income_taxes": 2929000000, "provision_for_income_taxes": 631000000, "net_earnings": 2298000000, "diluted_eps": 1.37, "earnings_for_basic_and_diluted_eps": 2292000000, "diluted_shares": 1670000000, "revenues_net_of_excise_taxes": 5356000000, "dividends_declared_per_share": 1.06 }, "balance_sheet": { "cash_and_cash_equivalents": 2367000000, "total_current_assets": 4022000000, "goodwill": 5787000000, "other_intangible_assets_net": 11850000000, "investments_in_equity_securities": 8896000000, "total_assets": 33374000000, "current_portion_of_long_term_debt": 1684000000, "total_current_liabilities": 7770000000, "long_term_debt": 22893000000, "total_liabilities": 35992000000, "total_stockholders_equity_attributable_to_altria": -2668000000, "noncontrolling_interest": 50000000, "total_stockholders_equity": -2618000000, "total_debt": 24577000000, "shares_outstanding_at_period_end": 1669743926 }, "segment_results": { "net_revenues": { "smokeable_products": 5392000000, "oral_tobacco_products": 713000000, "all_other": 6000000 }, "operating_companies_income": { "smokeable_products": 2942000000, "oral_tobacco_products": 381000000, "all_other": -77000000 }, "amortization_of_intangibles": -23000000, "general_corporate_expenses": -87000000 } }, { "label": "Q2 2025", "period_start": "2025-04-01", "period_end": "2025-06-30", "period_type": "three months", "source_accession": "0000764180-26-000094", "income_statement": { "net_revenues": 6102000000, "cost_of_sales": 1440000000, "excise_taxes_on_products": 812000000, "gross_profit": 3850000000, "marketing_administration_and_research_costs": 619000000, "asset_impairment_and_exit_costs": 1000000, "impairment_of_goodwill": 0, "operating_income": 3230000000, "interest_and_other_debt_expense_net": 275000000, "net_periodic_benefit_income_excluding_service_cost": -15000000, "income_losses_from_investments_in_equity_securities": -148000000, "earnings_before_income_taxes": 3118000000, "provision_for_income_taxes": 740000000, "net_earnings": 2378000000, "diluted_eps": 1.41, "earnings_for_basic_and_diluted_eps": 2371000000, "diluted_shares": 1684000000, "revenues_net_of_excise_taxes": 5290000000, "dividends_declared_per_share": 1.02 }, "segment_results": { "net_revenues": { "smokeable_products": 5357000000, "oral_tobacco_products": 753000000, "all_other": -8000000 }, "operating_companies_income": { "smokeable_products": 2930000000, "oral_tobacco_products": 498000000, "all_other": -108000000 }, "amortization_of_intangibles": -37000000, "general_corporate_expenses": -53000000 } } ], "year_to_date": { "label": "Six months ended June 30, 2026", "period_start": "2026-01-01", "period_end": "2026-06-30", "period_type": "six months", "source_accession": "0000764180-26-000094", "income_statement": { "net_revenues": 11539000000, "excise_taxes_on_products": 1425000000, "revenues_net_of_excise_taxes": 10114000000, "cost_of_sales": 2788000000, "gross_profit": 7326000000, "marketing_administration_and_research_costs": 1213000000, "asset_impairment_and_exit_costs": 21000000, "impairment_of_goodwill": 0, "operating_income": 6092000000, "interest_and_other_debt_expense_net": 553000000, "net_periodic_benefit_income_excluding_service_cost": -4000000, "income_losses_from_investments_in_equity_securities": -245000000, "earnings_before_income_taxes": 5788000000, "provision_for_income_taxes": 1307000000, "net_earnings": 4481000000, "earnings_for_basic_and_diluted_eps": 4470000000, "diluted_eps": 2.67, "diluted_shares": 1672000000, "dividends_declared_per_share": 2.12 }, "cash_flow": { "depreciation_and_amortization": 112000000, "net_cash_provided_by_used_in_operating_activities": 3043000000, "capital_expenditures": -150000000, "free_cash_flow": 2893000000, "net_cash_provided_by_used_in_investing_activities": -166000000, "net_cash_provided_by_used_in_financing_activities": -4988000000, "long_term_debt_issued": 0, "long_term_debt_repaid": -1069000000, "repurchases_of_common_stock": -335000000, "dividends_paid_on_common_stock": -3556000000 }, "segment_results": { "net_revenues": { "smokeable_products": 10150000000, "oral_tobacco_products": 1382000000, "all_other": 7000000 }, "operating_companies_income": { "smokeable_products": 5615000000, "oral_tobacco_products": 816000000, "all_other": -153000000 }, "amortization_of_intangibles": -46000000, "general_corporate_expenses": -140000000 } }, "prior_year_to_date": { "label": "Six months ended June 30, 2025", "period_start": "2025-01-01", "period_end": "2025-06-30", "period_type": "six months", "source_accession": "0000764180-26-000094", "income_statement": { "net_revenues": 11361000000, "excise_taxes_on_products": 1552000000, "revenues_net_of_excise_taxes": 9809000000, "cost_of_sales": 2710000000, "gross_profit": 7099000000, "marketing_administration_and_research_costs": 1207000000, "asset_impairment_and_exit_costs": 1000000, "impairment_of_goodwill": 873000000, "operating_income": 5018000000, "interest_and_other_debt_expense_net": 537000000, "net_periodic_benefit_income_excluding_service_cost": -29000000, "income_losses_from_investments_in_equity_securities": -291000000, "earnings_before_income_taxes": 4801000000, "provision_for_income_taxes": 1346000000, "net_earnings": 3455000000, "earnings_for_basic_and_diluted_eps": 3445000000, "diluted_eps": 2.04, "diluted_shares": 1687000000, "dividends_declared_per_share": 2.04 }, "cash_flow": { "depreciation_and_amortization": 142000000, "net_cash_provided_by_used_in_operating_activities": 2925000000, "capital_expenditures": -70000000, "free_cash_flow": 2855000000, "net_cash_provided_by_used_in_investing_activities": -79000000, "net_cash_provided_by_used_in_financing_activities": -4693000000, "long_term_debt_issued": 997000000, "long_term_debt_repaid": -1607000000, "repurchases_of_common_stock": -600000000, "dividends_paid_on_common_stock": -3454000000 }, "segment_results": { "net_revenues": { "smokeable_products": 9979000000, "oral_tobacco_products": 1407000000, "all_other": -25000000 }, "operating_companies_income": { "smokeable_products": 5399000000, "oral_tobacco_products": 931000000, "all_other": -1122000000 }, "amortization_of_intangibles": -74000000, "general_corporate_expenses": -116000000 } }, "trailing_twelve_months": { "label": "Trailing twelve months ended June 30, 2026", "period_start": "2025-07-01", "period_end": "2026-06-30", "period_type": "trailing twelve months", "source_accession": "0000764180-26-000017; 0000764180-26-000094", "income_statement": { "net_revenues": 23457000000, "excise_taxes_on_products": 3013000000, "revenues_net_of_excise_taxes": 20444000000, "cost_of_sales": 5675000000, "gross_profit": 14769000000, "marketing_administration_and_research_costs": 2513000000, "asset_impairment_and_exit_costs": 998000000, "impairment_of_goodwill": 285000000, "operating_income": 10973000000, "interest_and_other_debt_expense_net": 1095000000, "net_periodic_benefit_income_excluding_service_cost": -34000000, "income_losses_from_investments_in_equity_securities": -464000000, "earnings_before_income_taxes": 10376000000, "provision_for_income_taxes": 2403000000, "net_earnings": 7973000000, "earnings_for_basic_and_diluted_eps": 7952000000, "diluted_eps": 4.75, "diluted_shares": 1668000000, "dividends_declared_per_share": 4.24 }, "cash_flow": { "depreciation_and_amortization": 236000000, "net_cash_provided_by_used_in_operating_activities": 9408000000, "capital_expenditures": -296000000, "free_cash_flow": 9112000000, "net_cash_provided_by_used_in_investing_activities": -428000000, "net_cash_provided_by_used_in_financing_activities": -7910000000, "long_term_debt_issued": 995000000, "long_term_debt_repaid": -1069000000, "repurchases_of_common_stock": -735000000, "dividends_paid_on_common_stock": -7062000000 }, "derivation": "Derived by adding the six months ended June 30, 2026 to the year ended December 31, 2025 and subtracting the six months ended June 30, 2025." }, "notes": [ "Two filings are the source of everything here: Altria's annual report on Form 10-K for the year ended December 31, 2025 (accession 0000764180-26-000017) and its quarterly report on Form 10-Q for the quarter ended June 30, 2026 (accession 0000764180-26-000094). The 10-K's statements of earnings and cash flows print three years (2025, 2024 and 2023) and its balance sheets print two (December 31, 2025 and 2024); the 10-Q prints the second quarter and first half of 2026 against the same periods of 2025, a balance sheet at June 30, 2026, and cash flows for the six months only. Those are exactly the periods carried here.", "Altria's statement of earnings deducts two lines from net revenues before gross profit: cost of sales and excise taxes on products. Net revenues are therefore stated gross of excise taxes. The line 'revenues net of excise taxes' is not printed on the face of the statement; it is net revenues less excise taxes on products, and it is the revenue base Altria discusses in its own management commentary.", "Gross profit is net revenues less excise taxes on products less cost of sales; the deduction runs through three lines rather than the usual two.", "The line named 'asset_impairment_and_exit_costs' is the same position on the statement in both filings: the 10-K prints it as 'Asset impairment and exit costs' and the 10-Q prints it as 'Exit costs'. One name is used here so the periods line up.", "Total stockholders' equity is negative in every period shown. Altria's balance sheet reports a stockholders' equity deficit because the accumulated cost of repurchased stock (-$43.5 billion at June 30, 2026) exceeds earnings reinvested in the business. The figure stored as 'total_stockholders_equity' is the total including the $50 million noncontrolling interest, which is what the balance sheet balances against.", "Earnings per share: Altria reports a single 'basic and diluted' figure, so basic and diluted EPS are identical. Under the two-class method the EPS numerator is earnings after removing the portion attributable to unvested share-based awards, which is slightly less than net earnings; both figures are carried, as 'earnings_for_basic_and_diluted_eps' and 'net_earnings'. Weighted-average shares come from the earnings per share note in each filing (Note 12 in the 10-K, Note 7 in the 10-Q).", "Dividends declared per share are taken from the captions on the statements of stockholders' equity (deficit): $4.16, $4.00 and $3.84 for 2025, 2024 and 2023, and $1.06 and $1.02 for the second quarters of 2026 and 2025. Dividends paid on common stock in the cash flow block are the cash amounts, which differ from declared amounts because the fourth-quarter dividend is paid in January.", "Shares outstanding at each period end are issued shares (2,805,961,317 in every period) less the shares carried at cost of repurchased stock, as disclosed on the balance sheet. The June 30, 2026 figure of 1,669,743,926 is the same count Altria prints on the 10-Q cover page.", "Segment figures use Altria's own measure of segment profitability, operating companies income, which is operating income before general corporate expenses and amortization of intangibles. The reportable segments changed between the two filings: in the FY2025 10-K, e-vapor products met the quantitative threshold for separate presentation (because of the 2025 non-cash impairments) and Altria recast prior years to show it, so the annual segment tables here carry four lines. In the first quarter of 2026 Altria concluded e-vapor was no longer of continuing significance, removed it as a reportable segment, and folded it back into the all other category for all periods presented, so the quarterly and six-month segment tables here carry three. Annual and quarterly segment lines are consequently not directly comparable for e-vapor and all other; smokeable products and oral tobacco products are unaffected.", "The quarterly entries carry no cash flow figures. The 10-Q presents cash flows only for the six months ended June 30, 2026 and 2025, and Altria's first-quarter 2026 earnings release contains no cash flow statement, so there is no published three-month operating cash flow or capital expenditure figure to report. The six-month cash flows appear in 'year_to_date' and 'prior_year_to_date'.", "The trailing-twelve-months block covers July 1, 2025 through June 30, 2026 and is derived, not filed: the year ended December 31, 2025 plus the six months ended June 30, 2026 less the six months ended June 30, 2025, applied line by line to the income statement and the cash flow statement. Its diluted EPS ($4.75) and weighted-average share count (1,668 million) are derived the same way and are approximations of a true twelve-month weighted average.", "Free cash flow is operating cash flow less capital expenditures, with capital expenditures carried with the negative sign the cash flow statement prints.", "Total debt is the current portion of long-term debt plus long-term debt. Altria had no short-term borrowings outstanding at any of these period ends; the 10-K states that all long-term debt outstanding at December 31, 2025 and 2024 was fixed-rate, at a weighted-average coupon of approximately 4.5% and 4.3% respectively." ], "uncertainties": [ "No three-month cash flow statement exists for either quarter shown. Quarterly operating cash flow, capital expenditures and free cash flow are therefore absent rather than estimated.", "No balance sheet is published here for the quarter ended June 30, 2025. The 10-Q's balance sheet columns are June 30, 2026 and December 31, 2025 only. The statement of stockholders' equity does show total stockholders' equity (deficit) of -$3,206 million at June 30, 2025, but a single line is not a balance sheet and it is not carried as one.", "No balance sheet is published here for fiscal 2023. The FY2025 10-K's balance sheets cover December 31, 2025 and 2024 only.", "Trailing-twelve-months diluted EPS and the trailing-twelve-months weighted-average share count are arithmetic combinations of reported periods, not reported figures. Because weighted-average share counts cannot be added and subtracted exactly, treat both as approximate; trailing net earnings divided by the derived share count gives $4.78 against the $4.75 obtained by combining the reported per-share amounts.", "Altria's investments in equity securities are accounted for under the equity method, and the 10-K states that the audited financial statements of Anheuser-Busch InBev for the year ended December 31, 2025 will be filed by amendment within six months under Regulation S-X Rule 3-09. The equity-investment amounts carried here are as reported in the 10-K itself.", "The segment presentation changed between the two filings (e-vapor products was a reportable segment in the FY2025 10-K and is back inside 'all other' in the Q2 2026 10-Q). The annual and quarterly segment tables here each follow the filing they came from and have not been conformed to one another." ], "headline": { "period": "Q2 FY2026", "period_end_words": "June 30, 2026", "metrics": [ { "label": "Net revenues", "format": "usd", "value": 6111000000, "text": "$6.11 billion", "exact": "$6,111,000,000", "compact": "$6.11B", "abs": "$6.11 billion", "prior_value": 6102000000, "prior": "$6.10 billion", "priorabs": "$6.10 billion", "yoy": "up 0.1%", "source": { "array": "quarterly", "field": "income_statement.net_revenues", "index": 0, "period_label": "Q2 2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000764180-26-000094", "prior_index": 1, "prior_period_label": "Q2 2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000764180-26-000094", "gap_days": 365 } }, { "label": "Net earnings", "format": "usd", "value": 2298000000, "text": "$2.30 billion", "exact": "$2,298,000,000", "compact": "$2.30B", "abs": "$2.30 billion", "prior_value": 2378000000, "prior": "$2.38 billion", "priorabs": "$2.38 billion", "yoy": "down 3.4%", "source": { "array": "quarterly", "field": "income_statement.net_earnings", "index": 0, "period_label": "Q2 2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000764180-26-000094", "prior_index": 1, "prior_period_label": "Q2 2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000764180-26-000094", "gap_days": 365 } }, { "label": "Diluted EPS", "format": "eps", "value": 1.37, "text": "$1.37", "exact": "$1.37", "compact": "$1.37", "abs": "$1.37", "prior_value": 1.41, "prior": "$1.41", "priorabs": "$1.41", "yoy": "down 2.8%", "source": { "array": "quarterly", "field": "income_statement.diluted_eps", "index": 0, "period_label": "Q2 2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000764180-26-000094", "prior_index": 1, "prior_period_label": "Q2 2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000764180-26-000094", "gap_days": 365 } }, { "label": "Revenue net of excise taxes", "format": "usd", "value": 5356000000, "text": "$5.36 billion", "exact": "$5,356,000,000", "compact": "$5.36B", "abs": "$5.36 billion", "prior_value": 5290000000, "prior": "$5.29 billion", "priorabs": "$5.29 billion", "yoy": "up 1.2%", "source": { "array": "quarterly", "field": "income_statement.revenues_net_of_excise_taxes", "index": 0, "period_label": "Q2 2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000764180-26-000094", "prior_index": 1, "prior_period_label": "Q2 2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000764180-26-000094", "gap_days": 365 } }, { "label": "Smokeable products revenue", "format": "usd", "value": 5392000000, "text": "$5.39 billion", "exact": "$5,392,000,000", "compact": "$5.39B", "abs": "$5.39 billion", "prior_value": 5357000000, "prior": "$5.36 billion", "priorabs": "$5.36 billion", "yoy": "up 0.7%", "source": { "array": "quarterly", "field": "segment_results.net_revenues.smokeable_products", "index": 0, "period_label": "Q2 2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000764180-26-000094", "prior_index": 1, "prior_period_label": "Q2 2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000764180-26-000094", "gap_days": 365 } }, { "label": "Dividend declared per share", "format": "eps", "value": 1.06, "text": "$1.06", "exact": "$1.06", "compact": "$1.06", "abs": "$1.06", "prior_value": 1.02, "prior": "$1.02", "priorabs": "$1.02", "yoy": "up 3.9%", "source": { "array": "quarterly", "field": "income_statement.dividends_declared_per_share", "index": 0, "period_label": "Q2 2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000764180-26-000094", "prior_index": 1, "prior_period_label": "Q2 2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000764180-26-000094", "gap_days": 365 } } ], "summary": "Altria Group reported $6.11 billion in net revenues for Q2 FY2026, the quarter ended June 30, 2026, up 0.1% from a year earlier, with net earnings of $2.30 billion, down 3.4%, and diluted earnings per share of $1.37, down 2.8%. Revenue net of excise taxes was $5.36 billion, up 1.2%, as higher cigarette pricing lifted the smokeable products segment to $5.39 billion and offset lower cigarette shipment volume and a decline in oral tobacco revenue. Earnings slipped against a steady top line in part because operating income fell, held back by charges for the planned consolidation of U.S. Smokeless Tobacco Company manufacturing from Nashville, Tennessee to Hopkinsville, Kentucky and by higher general corporate expenses; lower income from investments in equity securities, lower net periodic benefit income and higher interest and other debt expense accounted for most of the remaining decline in pre-tax earnings; a lower income tax provision cushioned the fall in net earnings. Excluding the consolidation charge and other special items, Altria's adjusted net earnings and adjusted diluted earnings per share both rose. Altria declared a quarterly dividend of $1.06 per share in the quarter, up 3.9%.", "qa": [ { "q": "How much revenue did Altria report in Q2 FY2026?", "a": "Altria Group reported $6.11 billion in net revenues for Q2 FY2026, the quarter ended June 30, 2026, up 0.1% from $6.10 billion a year earlier. Excluding excise taxes billed to customers, revenue was $5.36 billion, up 1.2%." }, { "q": "What were Altria's earnings per share in Q2 FY2026?", "a": "Altria Group reported diluted earnings per share of $1.37 for Q2 FY2026, down 2.8% from $1.41 in the same quarter a year earlier, on net earnings of $2.30 billion. The reported decline is after a charge taken in the quarter for the planned consolidation of U.S. Smokeless Tobacco Company manufacturing; excluding that charge and other special items, Altria's adjusted diluted earnings per share rose." }, { "q": "Why did Altria's earnings fall in Q2 FY2026?", "a": "Altria Group's net earnings were $2.30 billion in Q2 FY2026, down 3.4% from $2.38 billion a year earlier, even though net revenues were up 0.1%. Operating income declined, reflecting charges for the planned consolidation of U.S. Smokeless Tobacco Company manufacturing to Hopkinsville, Kentucky, lower oral tobacco results and higher general corporate expenses, but that was only part of the fall in pre-tax earnings: lower income from investments in equity securities, lower net periodic benefit income and higher interest and other debt expense made up most of the rest; a lower income tax provision cushioned the fall in net earnings. Excluding the consolidation charge and other special items, Altria's adjusted net earnings rose." }, { "q": "How much of Altria's revenue comes from cigarettes?", "a": "Altria Group's smokeable products segment, which sells Marlboro and other cigarettes along with Black & Mild cigars, generated $5.39 billion of the company's $6.11 billion in net revenues in Q2 FY2026, up 0.7% from a year earlier on higher pricing against lower shipment volume." }, { "q": "What is Altria's quarterly dividend per share?", "a": "Altria Group declared a dividend of $1.06 per share in Q2 FY2026, the quarter ended June 30, 2026, up 3.9% from $1.02 a year earlier." } ] }, "company_details": { "Name": "Altria Group, Inc.", "Ticker": "MO", "CIK": "0000764180", "Exchange": "NYSE", "State": "Virginia", "Incorporation": "Virginia", "SIC": "2111", "Office": "Manufacturing", "Industry": "Cigarettes" }, "next_filing": { "predicted_date": "2026-10-29", "predicted_type": "10-Q" }, "fiscal_period": { "fiscal_year": 2026, "fiscal_period": "Q2", "tag": "FY26Q2", "period_end": "2026-06-30", "form": "10-Q", "accession": "0000764180-26-000094", "fiscal_year_end": "1231", "source": "facts" }, "source_filings": [ { "role": "annual", "current": false, "form": "10-K", "fiscal_year": 2025, "fiscal_period": "FY", "tag": "FY25", "period_end": "2025-12-31", "filed": "2026-02-25", "accession": "0000764180-26-000017", "url": "https://www.sec.gov/Archives/edgar/data/764180/000076418026000017/0000764180-26-000017-index.htm", "source": "reported" }, { "role": "quarterly", "current": true, "form": "10-Q", "fiscal_year": 2026, "fiscal_period": "Q2", "tag": "FY26Q2", "period_end": "2026-06-30", "filed": "2026-07-30", "accession": "0000764180-26-000094", "url": "https://www.sec.gov/Archives/edgar/data/764180/000076418026000094/0000764180-26-000094-index.htm", "source": "facts" } ] }